Purchase Order 75N95A26P00038
- Not listed
- This is a $5,359,557.00 cost-reimbursement contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to Medstar Health Research Institute Inc., a non-profit healthcare research organization. The contract is for "Clinical Support Services for the Research Efforts of the NINDS, Stroke Branch" and will provide 24/7 stroke care, MRI and CT scanning, lab tests, radiological services, and nurse coordinator support to support NINDS's research on the use of MRI...
- This is a $3,092,639.93 firm-fixed price contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Medstar Health Research Institute Inc. for stroke support services. The contract is a continuation of a long-standing collaboration between NINDS and local hospitals to provide clinical support for NINDS's research into acute cerebrovascular diseases and traumatic brain injury. Under the contract, Medstar will...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,900.00 contract to The Conjugate Group LLC, a small disadvantaged business, to provide regulatory affairs consultant support services. The contract has a base period of one year beginning September 2023 with two optional one-year extensions. The services are in support of the NIH Blueprint Neurotherapeutics program and the NIH HEAL Pain Therapeutics Development Program, as well as other NINDS...
- The U.S. National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services, awarded a $7,840 purchase order contract to Win Win Operations LLC, a small disadvantaged, woman-owned, and Black American-owned business, for medicinal chemistry consulting services and bioactivity assay development consulting services. The contract is set aside for small businesses and has a completion date of September 28, 2026. This award supports the NIH Blueprint...
- The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a firm-fixed-price delivery order contract to Remedybiz, Inc., a minority-owned small business. The $168,052.50 contract is for the provision of scientific services to support the Director of NINDS. This award is issued under the Information Technology Schedule 70 (IT-70) contract vehicle, a...
- The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, awarded a $10,000.00 firm-fixed price purchase order to Darryle Schoepp for Biological Therapeutics Consultation Services. The award has a completion date of July 1, 2025 and was made on July 2, 2024. There is no set-aside designation for this contract. The contract is for the provision of consultation services related to biological therapeutics, which aligns with NINDS's mission of supporting...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a delivery order valued at approximately $150K to Remedybiz, Inc. for subject matter expert consultation services. The contract, issued December 12, 2025, runs through December 11, 2026, and is structured as a firm fixed-price delivery order with work to be performed in Rockville, Maryland. This award was issued under the OASIS+ Small Business Multiple Award Contract, a government-wide General Services Administration...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a delivery order valued at $155,123.20 to CTR Management Group LLC (doing business as Convention Management Group) on April 15, 2021, with completion scheduled for April 30, 2022. The contract, issued under a firm fixed-price arrangement, provides administrative support services at the agency's Bethesda, Maryland location. CTR Management Group is a minority-owned, small disadvantaged business certified under the Small...
- The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $10,247.60 to Medical Research Support LLC, a self-certified small disadvantaged, economically disadvantaged, woman-owned small business located in Potomac, Maryland. The contract, which runs through November 30, 2024, will have Medical Research Support LLC provide medical research...
- <p>The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, awarded a $10,000 firm-fixed-price purchase order for biological therapeutics consultation services to the prime contractor, Hayley Sarah Mcloughlin. The services are to be provided to the Executive Oversight Committee (EOC) Board. The contract has a period of performance through July 16, 2025 and was awarded on July 17, 2024. This contract does not have a set-aside designation.</p>
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $21,450 firm fixed-price purchase order to Medical Research Support LLC, a women-owned small business based in North Potomac, Maryland, for clinical research support services. The contract, which runs from February 6, 2026 through February 5, 2027, supports a Phase 1/Phase 2 open-label trial evaluating LMP744, a novel indenoisoquinolone c-Myc/topoisomerase 1 inhibitor, in patients with recurrent glioblastoma. This award carries no set-aside designation and represents the continuation of Medical Research Support LLC's established track record providing specialized clinical data management and research support to federal agencies. Medical Research Support LLC, a sole proprietorship registered in the System for Award Management since February 2019, brings relevant expertise in clinical data management, database administration, and investigational new drug trial support. The company's prior work with the National Institutes of Health demonstrates proficiency in critical research functions including data entry, clinical database management, and adherence monitoring. This contract aligns with NINDS's mission to support research on neurological disorders and reflects the agency's investment in innovative therapeutic approaches for serious brain cancers such as glioblastoma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 2/5/26 |